Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  BG ControlType 1 DiabetesInsulinGlucose MonitoringIssue 681

Frequency of Blood Glucose Testing in Type 1's: How Often is Enough?

"Good diabetes control can be achieved in routine diabetes care with flexible intensified insulin therapy based on continuing patient education."...
Advertisement

As we know, self-monitored blood glucose (SMBG), as well as the knowledge of proper insulin use and requirements, is essential for proper metabolic control in patients with diabetes mellitus type 1. However, the question that this study tries to answer in particular is, what frequency of self monitoring of blood glucose is considered necessary for the most favorable glycemic control? 

This study focused especially on well-educated patients who understand the daily management of diabetes type 1 and the specific insulin requirements given. How often and to what extent SMBG should be executed on a daily basis remains unclear.

The study design used patients with type 1 diabetes and implemented a flexible and intensified insulin therapy. Intensive or flexible therapy involves using a constant supply of insulin to serve as the basalinsulin as well as providing mealtime insulin in doses relative to the nutritional load of the meals. Supplying extra insulin was also allowed when glucose levels were exceedingly high and in need of proper correction. These three components of the insulin regimen are commonly referred to as basal insulin, bolus insulin, and high glucose correction insulin methods.

Researchers evaluated HbA1c values and the directly preceding computerized SMBG-frequencies over a 12 month period. To approximate the relationship between HbA1c and SMBG-frequency the researchers used a fitted piecewise linear spline model with a change in slope at 4 SMBGs per day. The authors of the study recommended a minimal self monitoring blood glucose frequency of 4 times a day for best results.

The final study included a total of 150 patients who underwent the SMBG and HbA1c analysis. The study population used in the study had a median baseline HbA1c of 7.1% (interquartile range 6.6, 7.8). The final statistical assessment included a multivariable analysis which adjusted for gender and psychological problems. It was finally concluded that each added self monitoring blood glucose measurement by each patient was associated with an estimated difference in HbA1c of −0.19% (95% confidence interval (CI) −0.42, 0.05) for ≤4 SMBGs per day and of −0.02% (95% CI −0.10, 0.06) for >4 SMBGs per day.

What this statistical analysis ultimately illustrated was that optimal metabolic control was possible for diabetic type 1 patients with routine diabetes care, flexible and intensified insulin therapy coupled with continuing patient education and a minimum of 4 SMBGs checks per day.

A.Minder, D. Albrecht, J. Schäfer, and et al. "Frequency of blood glucose testing in well-educated patients with diabetes mellitus type 1: How often is enough?" Division of Endocrinology Diabetes and Metabolism, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.. Elsevier Ireland Ltd, 31 May 2013. Web. 4 Jun 2013.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 June, 2013 and appeared in  BG ControlType 1 DiabetesInsulinGlucose MonitoringIssue 681

Past five issues: Diabetes Clinical Mastery Series Issue 247 | Issue 787 | Diabetes Clinical Mastery Series Issue 246 | SGLT-2 Inhibitors Special Edition June 2015 | Issue 786 |

2015 Most Popular Articles:

Triple Therapy Improves Glycemia in Type 1 Diabetes
Posted June 19, 2015
Canagliflozin and Its Effects on Weight Loss and BP
Posted June 12, 2015
A Dual SGLT1/SGLT2 Inhibitor Can be a Treatment Option in Type 1 Diabetics
Posted June 12, 2015
Skin Bacteria a Cause of Diabetes?
Posted June 12, 2015
Lilly Insulin: A Better Alternative than Lantus?
Posted June 19, 2015
Blood Biomarkers May Predict Risk of Severe Hypoglycemia
Posted June 12, 2015
High Fiber Diets Reduce Risk of Diabetes
Posted June 04, 2015
Efficacy and Safety of an SGLT-2 Inhibitor with Insulin for Type 2s
Posted May 28, 2015
Tight Blood Glucose Control and Cardiovascular Disease
Posted June 12, 2015
Important Advances in Type 1 Diabetes Research
Posted June 25, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are you seeing more diabetic patients due to the Affordable Care Act?

CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .5